세계의 세포주 개발 시장(2024-2028년)

The cell line development market is forecasted to grow by USD 7.41 bn during 2023-2028, accelerating at a CAGR of 14.63% during the forecast period. The report on the cell line development market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increased demand for monoclonal antibodies, patent expiration of drugs, and rise in vaccine production.

Technavio's cell line development market is segmented as below:

By Product

• Media and reagents
• Equipment

By Source

• Mammalian
• Non mammalian

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the adoption of laboratory automation as one of the prime reasons driving the cell line development market growth during the next few years. Also, emergence of data integration and artificial intelligence (AI) and advancements in genetic engineering techniques will lead to sizable demand in the market.

The report on the cell line development market covers the following areas:

• Cell line development market sizing
• Cell line development market forecast
• Cell line development market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading cell line development market vendors that include ATCC, Boehringer Ingelheim International GmbH, Danaher Corp., DNA TwoPointO Inc., JSR Corp., Lonza Group Ltd., MabPlex International Ltd., Premas Biotech, Promega Corp., Sartorius AG, Thermo Fisher Scientific Inc., WuXi Biologics Cayman Inc., General Electric Co., and Corning Inc.. Also, the cell line development market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview

2 Market Landscape

• 2.1 Market ecosystem

3 Market Sizing

• 3.1 Market definition
• 3.2 Market segment analysis
• 3.3 Market size 2023
• 3.4 Market outlook: Forecast for 2023-2028

4 Historic Market Size

• 4.1 Global Cell Line Development Market 2024-2028 2018 - 2022
• 4.2 Product Segment Analysis 2018 - 2022
• 4.3 Source Segment Analysis 2018 - 2022
• 4.4 Region Segment Analysis 2018 - 2022
• 4.5 Country Segment Analysis 2018 - 2022

5 Five Forces Analysis

• 5.1 Five forces summary
• 5.2 Bargaining power of buyers
• 5.3 Bargaining power of suppliers
• 5.4 Threat of new entrants
• 5.5 Threat of substitutes
• 5.6 Threat of rivalry
• 5.7 Market condition

6 Market Segmentation by Product

• 6.1 Market segments
• 6.2 Comparison by Product
• 6.3 Media and reagents - Market size and forecast 2023-2028
• 6.4 Equipment - Market size and forecast 2023-2028
• 6.5 Market opportunity by Product

7 Market Segmentation by Source

• 7.1 Market segments
• 7.2 Comparison by Source
• 7.3 Mammalian - Market size and forecast 2023-2028
• 7.4 Non mammalian - Market size and forecast 2023-2028
• 7.5 Market opportunity by Source

8 Customer Landscape

• 8.1 Customer landscape overview

9 Geographic Landscape

• 9.1 Geographic segmentation
• 9.2 Geographic comparison
• 9.3 North America - Market size and forecast 2023-2028
• 9.4 Europe - Market size and forecast 2023-2028
• 9.5 Asia - Market size and forecast 2023-2028
• 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
• 9.7 US - Market size and forecast 2023-2028
• 9.8 Germany - Market size and forecast 2023-2028
• 9.9 China - Market size and forecast 2023-2028
• 9.10 UK - Market size and forecast 2023-2028
• 9.11 Japan - Market size and forecast 2023-2028
• 9.12 Market opportunity By Geographical Landscape

10 Drivers, Challenges, and Trends

• 10.1 Market drivers
• 10.2 Market challenges
• 10.3 Impact of drivers and challenges
• 10.4 Market trends

11 Vendor Landscape

• 11.1 Overview
• 11.2 Vendor landscape
• 11.3 Landscape disruption
• 11.4 Industry risks

12 Vendor Analysis

• 12.1 Vendors covered
• 12.2 Market positioning of vendors
• 12.3 ATCC
• 12.4 Boehringer Ingelheim International GmbH
• 12.5 Corning Inc.
• 12.6 Danaher Corp.
• 12.7 DNA TwoPointO Inc.
• 12.8 General Electric Co.
• 12.9 JSR Corp.
• 12.10 Lonza Group Ltd.
• 12.11 MabPlex International Ltd.
• 12.12 Premas Biotech
• 12.13 Promega Corp.
• 12.14 Sartorius AG
• 12.15 Thermo Fisher Scientific Inc.
• 12.16 WuXi Biologics Cayman Inc.

13 Appendix

• 13.1 Scope of the report
• 13.2 Inclusions and exclusions checklist
• 13.3 Currency conversion rates for US$
• 13.4 Research methodology
• 13.5 List of abbreviations